| Accession | PRJCA005206 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Title | Dynamic recurreAgriculturalnce risk and adjuvant chemotherapy benefit prediction by Circulating tumor DNA in resected non-small cell lung cancer | ||||||||
| Relevance | Medical | ||||||||
| Data types |
Targeted Locus (Loci)
Raw sequence reads Genome sequencing |
||||||||
| Organisms | Homo sapiens | ||||||||
| Description | In this study, we sought to evaluate the utility of ultradeep targeted next-generation sequencing (NGS) on serial longitudinal ctDNA sampling post-surgery in resected NSCLC patients for MRD detection and ACT treatment decision-making, and dynamic risk prediction of recurrence during post-surgical and post-ACT disease surveillance. | ||||||||
| Sample scope | Multiisolate | ||||||||
| Release date | 2021-05-20 | ||||||||
| Grants |
|
||||||||
| Submitter | GUO WEI (guowei@cicams.ac.cn) | ||||||||
| Organization | National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College | ||||||||
| Submission date | 2021-03-17 |
| Resource name | Description |
|---|---|
| BioSample (568) show | - |